Ignace Vergote - Wissenschaftliche Veröffentlichungen

(1 - 5 von 8

)

European Journal of Cancer - ScienceDirect.com

www.sciencedirect.com

von I Vergote · · Zitiert von: 3 — The analysis indicates that the relative clinical benefit of bevacizumab appears to be additive and consistent across regimens. Contributors. Ignace Vergote: ... › pii

dblp: Ignace Vergote

dblp.uni-trier.de

List of computer science publications by Ignace Vergote

Seminars in Oncology | New Developments in Gynecologic Malignancies |...

www.sciencedirect.com

New Developments in Gynecologic Malignancies. Eli Lilly and company. Edited by Robert F. Ozols, Ignace Vergote. Volume 33, Supplement 6, Pages A1-A2, ...